Extraction temperature of sample has significant effects on kinetic process (Pawliszyn 2000) because it determines vapor pressure of analytes in the sample.
Since these galaxies tend to have lower dust attenuation than LIRGs/ULIRGs, they are similar to the lower-IR luminosity galaxies in our sample having significant UV fluxes, as we have seen in Fig. 9. Hence, we conclude that low-luminosity IR galaxies have a common attenuation strength with UV-luminous starbursts.
Finally, although our overall sample had significant proportions of non-Caucasian subjects, the samples were too small for meaningful genetic analysis; collaborative studies need to be established to study how genetic polymorphisms affect AIAA in minority populations.
There are several low absorption windows at 800-900 nm and 1 µm and these spectral regions are preferred for applications where the sample has significant water content (like in ophthalmic applications where imaging is performed through more than 2 cm of water).
These statistical tests indicate, whether two independent samples have significant differences.
The NSO compounds of the two samples have significant differences, while the molecular composition of these NSO compounds can be confirmed through their accurate molecular weights (Table 2).
At 950 °C, the samples have significant interconnected open porosity and therefore high water absorption values for surfaces highly accessible to water.
Figure 5C (left) shows that the secretory SqCC samples have significant (P 7.5e-05) lower proliferation scores than other subtypes.
Poplar types' propolis from Europe, Asia, and North America is characterized by the presence of pinocembrin, pinobanksin, galangin and benzyl, phenethyl, and prenyl caffeates; Northern Russia samples have significant levels of acacetin, apigenin, ermanin, and kaempferide.
If the clinical values of these two groups of samples have significant difference, a clinical subtype of genotype-phenotype association (e.g., the correlation between clinical indices and pathway DEVGs) is identified and the corresponding pathway is a subtype-factor corresponding to the given clinical index.
